Evidence map›Paper›PMID 35585305›Full record

ArticleApplied health economics and health policy2022

ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients.

Kristyna Lacinova, Praveen Thokala, Richard Nicholas, Pamela Dobay, Erik Scalfaro, Zuzanna Angehrn, Roisin Brennan, Ibolya Boer, Carol Lines, Nicholas Adlard

Abstract read
In one paragraph

Article in Applied health economics and health policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kristyna LacinovaSimul8 Corporation Ltd, Glasgow, UK.
Praveen ThokalaPT Health Economics Ltd, Sheffield, UK. praveen.thokala@gmail.com.
Richard NicholasImperial College London, London, UK.
Pamela DobayIQVIA AG, Basel, Switzerland.
Erik ScalfaroIQVIA AG, Basel, Switzerland.
Zuzanna AngehrnIQVIA AG, Basel, Switzerland.
Roisin BrennanNovartis Global Services Centre, Dublin, Ireland.
Ibolya BoerNovartis Pharma AG, Basel, Switzerland.
Carol LinesNovartis Pharma AG, Basel, Switzerland.
Nicholas AdlardNovartis Pharma AG, Basel, Switzerland.ORCID 0000-0001-6912-1685

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImproved multiple sclerosis (MS) diagnosis and increased availability of intravenous disease-modifying treatments can lead to overburdening of infusion centres. This study was focused on developing a decision-support tool to help infusion centres plan their operations.

methodsA discrete event simulation model ('ENTIMOS') was developed using Simul8 software in collaboration with clinical experts. Model inputs included treatment-specific clinical parameters, resources such as infusion chairs and nursing staff, and costs, while model outputs included patient throughput, waiting time, queue size, resource utilisation, and costs. The model was parameterised using characteristics of the Charing Cross Hospital Infusion Centre in London, UK, where 12 infusion chairs were deployed for 170 non-MS and 860 MS patients as of March 2021. The number of MS patients was projected to increase by seven new patients per week.

resultsThe model-estimated waiting time for an infusion is, on average, 8 days beyond clinical recommendation in the first year of simulation. Without corrective action, the delay in receiving due treatment is anticipated to reach 30 days on average at 30 months from the start of simulation. Such system compromise can be prevented either by adding one infusion chair annually or switching 7% of existing patients or 24% of new patients to alternative MS treatments not requiring infusion.

conclusionENTIMOS is a flexible model of patient flow and care delivery in infusion centres serving MS patients. It allows users to simulate specific local settings and therefore identify measures that are necessary to avoid clinically significant treatment delay resulting in suboptimal care.

Indexed as

Multiple SclerosisComputer SimulationHospitalsHumansSoftware

Identifiers

PMID35585305
PMCPMC9117085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.